	vwf	16.95549399029536
	clone Factor VIII	11.718300890888118
	Human Factor VIII	11.54320631367304
	unbound Factor VIII	11.522361821710739
¡°	truncate Factor VIII protein	10.835639177274453
	partially purify Factor VIII	8.603365648354522
	Factor VIII performance	8.583937509245862
¡°	truncated Factor VIII protein	8.302330636009092
¡°	truncate recombinant Factor VIII protein	7.526068564873043
¡°	truncated recombinant Factor VIII protein	7.22091797669765
	truncated human Factor VIII protein	6.93764008201019
	plasma derive Factor VIII	6.904207371727386
¡°	commercial recombinant Factor VIII protein	6.858426792699896
	native human Factor VIII protein	6.638474191772263
	full length Factor VIII protein	5.622113612707958
	a3 region	4.083088602828144
	assertion	3.068638448994094
	functional a3 acidic region	2.5835156918262383
	jurisdictional argument	2.335727717298474
	porcine	2.086022675707315
	truncate form	2.003741569966586
	certain amino acid	1.425744911006718
	recombinant human blood clot protein	1.2838765048958232
	large blood protein	1.2782086739693612
	amino acid sequence	1.1456607227221434
	allowable amino acid substitution	1.1346410879706375
	von Willebrand factor	1.0968326450145864
	permit amino acid deletion	1.0495004907436951
	procoagulant activity	0.975925652480382
	essential blood clot protein	0.9643021550255187
	small easily clone recombinant protein	0.9572053069941442
	A1	0.8350261861970659
	a2	0.8350261861970659
	A3	0.8350261861970659
	HIV	0.8350261861970659
	hemophilia	0.8346146404496607
	vivo cleavage site	0.7771984958870012
	vivo cleavage point	0.7612956008875894
	vivo cleavage cite	0.7612883510961185
	genetic disorder	0.75133644137708
	recombinant dna	0.7246328763919685
	Wyeth	0.722319672091525
	medichem	0.722319672091525
	invalidity contention	0.6694638337841784
	nucleic acid	0.6513018887610066
	dna cloning	0.597535067616263
	blood coagulation	0.5289933788890232
	Pl.-Appellant Reply Br	0.5275647052473382
	Grabiak	0.5035230021110174
	two acidic region	0.49392363311671844
	hepatitis	0.48166518229959937
	inactive B domain	0.45228719081829905
	disclaimer	0.44852420501026197
	Vectra Fitness	0.44003697722412427
	a1	0.41761608103884734
	Litecubes	0.41761608103884734
	Kopf	0.41761608103884734
	Large region	0.41203111478860616
	several region	0.4092535337832195
	inactive b domain	0.40923274932345055
	residue	0.4044676095469236
	unwanted clot	0.3771266749767838
	third acidic region	0.3707140895706934
	two polypeptide	0.3611599204420953
	c2	0.33576477005199695
	virus	0.33576477005199695
	three specific deletion	0.3228706217712984
	deletion point	0.32279840994265135
	follow domain	0.3193864462649281
	Dillon	0.3086850676506574
	cloning process	0.27834964597312034
	collectively	0.2782516283477386
	Vitro Procoagulant Activity	0.27547729164125373
	Diagnostics	0.26995377141191323
	subsection	0.26995377141191323
	C1	0.25444744460938246
	Def.-Appellee Br	0.24601502990374577
	Compl	0.24089199731677524
	allegedly interfere	0.22756247090972065
	interfere suit	0.22498066526431834
	interfere action	0.22496400578335082
	two interfere	0.22496356519549562
	inactive state	0.22373289794318763
	dna sequence	0.22191797167520866
	researcher	0.20918668734470894
	unexpired	0.2022338047734618
	second leg	0.2021436881317622
	first leg	0.2021342800859811
	c domain portion	0.19774638197659447
	damaged blood vessel	0.1944588291655757
	In particular deletion	0.19368191745418478
	Lalu	0.16812443113548223
	Morgan	0.1679237965681386
	Zenon Envtl	0.150212714466908
	blood platelet	0.14873234985813022
	scientist	0.14079111353458498
	Oakley	0.13941288788852604
	Slip Track Systems	0.13627824337321617
	host cell	0.1270050893513492
	enormous technical undertaking	0.1209262381432144
	prolong bleeding	0.11422341108906295
	sine qua	0.1119491977120924
	Sanofi Synthelabo	0.1028315502302129
	interference action	0.10015952336124963
	i. Appellate Jurisdiction	0.09861130084383012
	human plasma source	0.09840953451936375
	Nat'l Acad	0.0981668183718508
	expiration situation	0.09089917876033365
	E.D.Tex	0.08305477566963426
	Sunglass Hut	0.06972363843039323
	original expiration date	0.06791374288706685
	regulatory review	0.06753834769419109
	term extension application	0.06379289397205565
	Metal Lite Inc.	0.06225062254166247
	N. Light Prods	0.05900786744214446
	District Court Jurisdiction	0.055356195735524714
	invocation	0.051510943215938285
	Medichem	0.051510943215938285
	Rolabo	0.051510943215938285
	Takeda Chem	0.04675630415261175
	S.L.	0.04504776825118263
	heart vessel	0.04172998647220606
	H Corp.	0.04152738838522419
	biological activity	0.040619027380590464
	prima facie case	0.0362090975636084
	satisfaction	0.035323327226295165
	Sci	0.035323327226295165
	increase stability	0.03285588811190154
	writing	0.031592759959191016
	optimal regulation	0.031587565917063534
	civil action	0.03158593446804295
	expansive reading	0.030736399257116395
	Sage Prods	0.03042835385155727
	structural similarity	0.03016143634371255
	Devon Indus	0.03009763630444932
	heavy chain	0.029896833134988383
	original seventeen year term	0.02904754460642006
	chemical building block	0.026226605391283183
	whose expression	0.025939723558323594
	extended term	0.025841401445224912
	defect	0.025668710945613665
	retain portion	0.024999175686310483
	light chain	0.024787230461761175
	safe abundant source	0.02125818196442237
	appx	0.02120773610882909
	well plead complaint	0.020770320786744866
	Delaware	0.020440473626899807
	legislative history	0.019855677329965675
	prior art compound	0.01658676098815537
	restriction	0.01654890293121153
	PTO regulation	0.01643779990708328
	payment	0.015026685538268372
	therapeutic material	0.013869040579164122
	motivation	0.013760199002794854
	Apotex	0.013255956064101801
	Congress	0.012830740602134398
	real world consequence	0.012546962284635713
	party divergent interpretation	0.012015424725543738
	February	0.01182325355664267
	priority date	0.011465498192959387
	sectional interest	0.011422494511118755
	value	0.011403853327217217
	past damage	0.01075354047962762
	relief	0.010507417930205298
	large size	0.010432918852953575
	comparable statute	0.010271908505611563
	reaction	0.010263061423718899
	memorandum opinion	0.010026279672149679
	memorandum order	0.010016790602817799
	particular importance	0.009398519486621426
	J.A.	0.00935708689492365
	rather unusual step	0.008951828481488682
	Hatch Waxman Act	0.008933742498244442
	Jr.	0.008910906781359034
	wholly subsidiary	0.00880612647339222
	approve product	0.00852752516146118
	subsequent elimination	0.00847482100248523
	patient	0.007419480147623964
	Kimberly Clark Corp.	0.007411583230802001
	three dimensional structure	0.007314967678481853
	narrow range	0.007235584640114916
	broad range	0.007106363977622745
	party settlement	0.007102504581191643
	LLC	0.006873498925163766
	title	0.006815171202026553
	active ingredient	0.0060965803096674695
	structural difference	0.006064282098370178
	testing	0.005999003414289217
	Lourie	0.005297511831481291
	provision	0.005296205416673322
	statutory text	0.0051447793985463725
	internal quotation mark	0.004987794905400766
	drug use	0.004683770907485484
	Texas	0.0044208317397456745
	composition	0.004195309583519594
	half life	0.004163750014859535
	one essential difference	0.0035901964077849706
	S.A.	0.003310932376658221
	account	0.003310932376658221
	infringement liability issue	0.0029703029480905
	contrast	0.0029474174698852283
	meaningful difference	0.0028314446573924706
	appellate jurisdiction	0.002588426575514518
	plain language	0.0025503246180417004
	two statute	0.0025098155281324344
	Figure	0.0023461857564309654
	related case	0.0021875354624033574
	important distinction	0.00214472588490684
	similar reasoning	0.0020914177198622765
	treatment	0.0020732085464409676
	independent obligation	0.0020583051375223306
	statutory language	0.0017816724084606076
	two article	0.0016959243038902063
	deposition	0.0016554661883291105
	instruction	0.0016418363656855936
	district court entry	0.0016402218624220987
	April	0.0016280401643243246
	Idaho anticipation	0.0015760034567677045
	knowledge	0.0014364786501940938
	statutory interpretation	0.0013276013488717389
	Teleflex Inc.	0.0013254665889711331
	September	0.0012715229084941271
	effort	0.0012692807186069298
	sole inventor	0.0012337117186347537
	one pende application	0.0012075595931190098
	accordance	0.0010904621698706498
	adequate support	0.0010128432498534296
	anticipation obviousness inquiry	0.001012037714725464
	timely notice	0.0010038067030592667
	second paragraph	0.00099614828839681
	area	0.000937784627504948
	May	0.0009360164609792978
	latter point	0.0008926685709614801
	six year limitation	0.0007683632553671981
	complete	0.0006951087110175829
	Eastern District	0.0006750896251149557
	oppose party	0.0005945722633251606
	commercial product	0.0005530145541539325
	name	0.0005429477585186469
	commercial use	0.0005417756512509847
	owner	0.0004435277692691655
	patented technology	0.00043703519617703973
	March	0.0004240500499927881
	Supreme Court opinion	0.0003807979318691157
	explicit limitation	0.0003532019137736709
	lack	0.00034962565949786013
	cover	0.00030706097341430365
	brief	0.0002995937106442431
	principle	0.0002853202662318996
	hand	0.0002560270538694768
	two way test	0.00023046360163959695
	right	0.00022653008842105917
	substantially subject matter	0.00022099898361809607
	method	0.00020839753136726259
	holding	0.00020548849820134184
	relevant field	0.00020194810680480155
	obviousness de novo	0.00019475758098589158
	underlie question	0.00018425198374335898
	response	0.00015989230398697724
	particular manner	0.00015445328316903906
	subject matter jurisdiction	0.000146795514570365
	patentee asserted competitor	0.00014600741344893744
	en banc	0.00013712015793227144
	underlie factual determination	0.00012966824259790107
	available prior art	0.00012636384435960914
	underlie finding	0.00012597232747556982
	legal effect	0.00012537502827414366
	emphasis	0.00012353516431364803
	final judgment	0.00010067295981187612
	certain issue	0.0001006032571150815
	prior art teaching	9.985193804982597e-05
	first step	9.220238569848682e-05
	substantial difference	8.735846648251098e-05
	require content	7.779431150912074e-05
	United States Patent Trademark Office	7.226119687636236e-05
	two type	6.373996195906131e-05
	turn	6.330084548281431e-05
	example	5.303409547913576e-05
	district court final decision	5.162458424381221e-05
	every limitation	4.8229588423313386e-05
	properly construe	4.8034630487146976e-05
	addition	4.3853908614653496e-05
	ordinary skill	4.276163779486397e-05
	obvious subject matter	4.105222704964193e-05
	background	4.006977975711262e-05
	Ltd.	3.686471979007213e-05
	dispute language	3.349244985193688e-05
	change	3.331746622195742e-05
	expert	2.8059562859639255e-05
	Claim	2.5555152767059807e-05
	clear error	2.1178386268726883e-05
	neither	2.059806785817177e-05
	legal conclusion	2.0405106479362754e-05
	summary judgment	1.2419854535566717e-05
	factual finding	6.8098943921106985e-06
	district court opinion	6.57934363281814e-06
	construction	6.4425155042801655e-06
	single prior art reference	6.101178616425342e-06
	district court analysis	4.786179573421274e-06
	prior art subject matter	4.510080669648252e-06
	first time	3.1892726686716286e-06
	patentee appeal	2.9756620895897032e-06
	district court determination	1.9187147465525525e-06
	district court conclusion	1.0227072278913794e-06
	trial court	6.623989991859133e-07
	present appeal	5.897457676309558e-07
	one party	7.295547097850153e-08
	invention	2.190274491227915e-08
	whether	2.071287267405179e-08
	district court judgment	5.4126813647333725e-09
	Appeals	0.0
	Fed	0.0
